Are we edging closer to precisely, and safely, editing human embryos?

On June 1, an international group of industry and academic collaborators, led by geneticist Dieter Egli at Columbia University, released a preprint on bioRxiv demonstrating the use of base editing in human embryos (2026, DOI: 10.64898/2026.05.30.728989).

Base editing, which allows for precise swapping of one nucleotide for another without creating destructive double-strand breaks in DNA, is an evolution of CRISPR gene editing technology.

Although the base editing didn’t result in aneuploidy, it still had significant off-target effects. The researchers observed editing at sites other than the gene of interest and cases of mosaic embryos, in which not all the cells in the embryo carry the gene edits. For those reasons, the authors argue, more work and ethics discussions are necessary before using genetically edited embryos for clinical in vitro fertilization (IVF).

…

Related on the SLP

Embryo gene editing is on the horizon, stirring mixed emotions Ethical and science conundrum: Did reporters, scientists miss nuances of embryo gene-editing story?

Viewpoint: RFK Jr. touts AI to guide health care…but searches using the technology he champions expose him as scientifically illiterate

Viewpoint: ‘Bureaucratic and economic obstacles’ to agricultural biotechnology: Europe creeps into the 21st century, but blocks remain

Viewpoint: How the anti-abortion movement twists medical facts and promotes science misinformation

[David] Barrett has a few blunt words to spare for those who see genetic editing of embryos just beyond the horizon: “Science is not ready for heritable human genome editing.”

This is an excerpt. Read the original post here